glp 1 drug ingredients GLP-1 Companion Health Pack Daily Packets GreenLab GLP-1 Supplement for Women

Harnessing glucagon-like peptide-1 receptor agonists for the pharmacological treatment of overweight and obesity

Rather than targeting more receptors with a single molecule, it combines two separate compounds, cagrilintide (an amylin analogue) and semaglutide (a GLP-1 agonist), into a single weekly injection

Zhang L, Yang M, Ren H, Hu H, Boden G, Li L, et al

Dipeptidyl peptidase-4 inhibition prevents nonalcoholic steatohepatitis-associated liver fibrosis and tumor development in mice independently of its anti-diabetic effects

It works like a GLP-1 agonist, but also targets a hormone called glucose-dependent insulinotropic polypeptide (GIP) to help break down sugar and fat, according to Chatham

Semaglutide may be the right starting point if you: Are new to GLP-1 therapy and want to start with the most established option Have a moderate amount of weight to lose Don't have significant insulin resistance or type 2 diabetes Want a well-documented safety profile with years of real-world data Tirzepatide may be the stronger option if you: Have a higher BMI or significant amount of weight to lose Have insulin resistance, prediabetes, or type 2 diabetes Have tried Semaglutide previously with limited results Want the most aggressive metabolic intervention currently available Are dealing with significant visceral fat or metabolic syndrome The Most Important Factor: Medical Guidance The right medication is the one your provider determines is appropriate for your health history, labs, BMI, and goals not the one that sounds more advanced or that someone else is using